Ectonucleoside triphosphate diphosphohydrolase-1 also known as CD39, is a typical cell surface enzyme with a catalytic site on the extracellular face. From Wikipedia
Successful brain repair after delayed dosing confirms the promise of CD39/A3AR targeting, paving the way for human trials.
